NCT04837781

Brief Summary

The aim of this study is to evaluate the effect of vitamin D3 deficiency on the rate of orthodontic tooth movement in both conventional and accelerated orthodontic. Assessing both lower anterior teeth alignment and the rate of maxillary canine retraction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 23, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2021

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

April 6, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
Last Updated

April 12, 2021

Status Verified

April 1, 2021

Enrollment Period

1.9 years

First QC Date

April 6, 2021

Last Update Submit

April 7, 2021

Conditions

Keywords

Orthodontic, tooth movement, acceleration

Outcome Measures

Primary Outcomes (4)

  • Canine retraction rate

    Maxillary study model will be 3D scan using optical 3D scanner(Smart Optic,Germany) then measurement done on digital model using 3D program( DentalCad,Galway,3.0,2021),to measure distance from tip of canine to 3rd palatal raguea on both side

    4 weeks

  • Canine retraction rate

    Maxillary study model will be 3D scan using optical 3D scanner(Smart Optic,Germany) then measurement done on digital model using 3D program( DentalCad,Galway,3.0,2021),to measure distance from tip of canine to 3rd palatal raguea on both side

    8 weeks

  • Canine retraction rate

    Maxillary study model will be 3D scan using optical 3D scanner(Smart Optic,Germany) then measurement done on digital model using 3D program( DentalCad,Galway,3.0,2021),to measure distance from tip of canine to 3rd palatal raguea on both side

    12 weeks

  • Canine retraction rate

    Maxillary study model will be 3D scan using optical 3D scanner(Smart Optic,Germany) then measurement done on digital model using 3D program( DentalCad,Galway,3.0,2021),to measure distance from tip of canine to 3rd palatal raguea on both side

    16 weeks

Secondary Outcomes (5)

  • Alignment efficiency

    4 weeks

  • Alignment efficiency

    8 weeks

  • Alignment efficiency

    12 weeks

  • Root resorption

    12 weeks

  • pain perception

    7 days

Study Arms (3)

Normal vitamin D

EXPERIMENTAL

Include patients with normal vitamin D level (above 30ng/ml). Vitamin D level will be measured at the beginning of treatment if there is deficiency then the patient refer to specialized physician to be supplied with vitamin D supplement to optimized the level to normal then start orthodontic treatment

Procedure: Micro-osteoperforation

Vitamin D deficiency

EXPERIMENTAL

Include patients with unknown vitamin D level until time of canine retraction where we measure level if deficiency exist (below 30ng/ml) then the patient will be referred to specialized physician to be supplied with vitamin D supplement.

Procedure: Micro-osteoperforation

Control

EXPERIMENTAL

includes patients with unknown vitamin D level until the completion of canine retraction where we measure level. If deficiency exists (below 30ng/ml) then we will refer the patient to specialized physician to be supplied with vitamin D supplement

Procedure: Micro-osteoperforation

Interventions

Micro-osteoperforation Mini-implant facilitated micro-osteoperforation (MOPs) were placed in the experimental side before canine retraction. Three MOPs were placed distal to canine on experimental sides in all group.

Also known as: MOP
ControlNormal vitamin DVitamin D deficiency

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age ranged from 18 to 30 years, from both sex.
  • Healthy general medical condition, healthy periodontal condition.
  • Malocclusion that requires extraction of the maxillary first premolars, followed by canine retraction, with moderate lower incisor crowding (Little's irregularity index 3-6mm).
  • Normal shape and structure of maxillary canine, with no history of filling or root canal treatment and normal shape and structure of maxillary first molar.

You may not qualify if:

  • Pregnant women.
  • Patient with renal or liver disease.
  • Patient taking corticosteroid or anticonvulsant drugs.
  • Patient with thyroid or parathyroid problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Dentisry-University of Baghdad

Baghdad, Al-Rusafa, Iraq

Location

Related Publications (1)

  • Al-Attar A, Abid M. The Effect of Vitamin D3 on the Alignment of Mandibular Anterior Teeth: A Randomized Controlled Clinical Trial. Int J Dent. 2022 Feb 14;2022:6555883. doi: 10.1155/2022/6555883. eCollection 2022.

Study Officials

  • Mushriq Abid, MSc, PhD

    University of Baghdad

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Blinding to treatment allocation was possible only for the investigator and data analyst because the clinicians could know the intervention as osteo-perforation can be obviously seen clearly. Masking the intervention for the participants were not possible because micro-osteoperforation is a surgical procedure. All the trial documents were labeled with the study ID number, which was used for participant identification and data collection without unmasking the allocation group. This allowed the investigator to complete data collection and measurements blindly.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 6, 2021

First Posted

April 8, 2021

Study Start

February 23, 2019

Primary Completion

February 2, 2021

Study Completion

March 8, 2021

Last Updated

April 12, 2021

Record last verified: 2021-04

Locations